The Predictive Effects of Clinical Hematological Changes on Saphenous Graft Patency after Coronary Artery Surgery
AUTOR(ES)
İyigün, Taner
FONTE
Braz. J. Cardiovasc. Surg.
DATA DE PUBLICAÇÃO
22/07/2019
RESUMO
Abstract Objectives: To investigate the association between clinical hematologic parameters and saphenous vein graft failure after on-pump coronary artery bypass surgery. Methods: A total of 1950 consecutive patients underwent isolated on-pump coronary artery surgery between November 2010 and February 2013. Of these, 284 patients met our inclusion criteria; their preoperative clinical hematological parameters were retrospectively obtained for this cohort study. And of them, 109 patients underwent conventional coronary angiography after graft failure was revealed by coronary computed tomography angiography. The primary endpoint was to catch at least one saphenous vein graft stenosis or occlusion following the coronary angiogram. We then analyzed risk factors for graft failure. In sequential or T grafts, each segment was analyzed as a separate graft. Results: In logistic regression analysis, older age, platelet distribution width, and diabetes mellitus were identified as independent predictors of saphenous vein graft failure (P<0.). In contrast, preserved ejection fraction value favored graft patency (P<0.001). Conclusion: Increased platelet distribution width is easily measurable and can be used as a simple and valuable marker in the prediction of saphenous vein graft failure.
Documentos Relacionados
- Effects of massage therapy on sleep quality after coronary artery bypass graft surgery
- The Effects of Preoperative Coronary Collateral Circulation on Cardiac-Related Events after Coronary Artery Bypass Graft Surgery
- Clinical and angiographic prediction of cardiac death after coronary artery bypass graft surgery.
- Lung function after coronary artery surgery using the internal mammary artery and the saphenous vein.
- Predictive value of ventricular arrhythmias for patency of the infarct-related coronary artery after thrombolytic therapy.